Algeria begins producing the CoronaVac COVID-19 vaccine developed by Sinovac, with expected production of eight million

COVID-19 pandemic

Algeria begins producing the CoronaVac COVID-19 vaccine developed by Sinovac, with expected production of eight million doses per month.

Algeria begins Sinovac Covid-19 vaccine production - France 24 © France 24

Changes

Algeria begins to producing the CoronaVac COVID-19 vaccine developed by Sinovac, with production expected to be eight million doses a month.
2021-09-29 21:06:20 (First version)

Algeria begins producing the CoronaVac COVID-19 vaccine developed by Sinovac, with expected production of eight million doses per month.
(Current version)

Offstream
news

2021-09-29

COVID-19 pandemic

Algeria begins producing the CoronaVac COVID-19 vaccine developed by Sinovac, with expected production of eight million doses per month.

Changes

Related